Teresa Sanchez Garcia Vao, PhD

Associate Professor of Pathology and Laboratory Medicine

Contact & profiles

Appointments

Associate Professor of Pathology and Laboratory MedicinePrimary
Pathology and Laboratory Medicine · 2023–
Florence Gould Foundation Research Scholar for Discovery in Stroke
Pathology and Laboratory Medicine · 2024–
Associate Professor
Weill Cornell Graduate School — Neuroscience · 2024–

Past Appointments

Associate Professor of Neuroscience
Brain and Mind Research · 2023–2026
Assistant Professor of Neuroscience
Brain and Mind Research · 2017–2023
Assistant Professor of Pathology and Laboratory Medicine
Pathology and Laboratory Medicine · 2015–2023

Centers

Education

Ph.D., Pharmacology, Cell and Molecular Biology
University of Barcelona (Spain), 2001
M.S., Pharmacology
University of Barcelona (Spain), 1997
Pharm.B.
University of Barcelona (Spain), 1996

Highlights

1
Proceedings of the National Academy of Sciences of the United States of America · 2023
JZJenny Zhaoying Xiang TSTeresa Sanchez Garcia Vao
PMID: 37058487PMCID: PMC10120001DOISenior author18 citations
2
eNeuro · 2024
PÁPaulo Ávila Gómez GFGiuseppe Faraco LGLidia Garcia Bonilla JAJosef Anrather+2 more →TSTeresa Sanchez Garcia Vao
PMID: 39266325PMCID: PMC11439565DOISenior author5 citations

6 grants

PI
Endothelial Sphingolipid Signaling in Cerebrovascular Inflammation and Cognitive Decline: Mechanisms and Therapeutic Potential.
National Institute on Aging · 2026–2031
R01NS147357-01
PI
Unraveling Mechanisms and Novel Therapeutic Strategies in Cerebral Microvascular Dysfunction and Cognitive Impairment.
American Heart Association · 2025–2030
AHA 246523-02
PI
Role and therapeutic targeting of the cerebral microvasculature in dementia
Alzheimer's Association National Office · 2025–2028
25AARG-NTF-1365666
PI
BioPharma Alliance Agreements with Critical Path Institute
Critical Path Institute · 2026–2027BioPharma Alliance
BP 262108-01
PI
Biopharma Agreement with Sanofi S.A
Sanofi S.A. · 2025–2027BioPharma Alliance
BP 255215-01
PI
Endothelial Sphingolipid Signaling in Neurovascular Ischemic Injury
National Institute of Neurological Disorders and Stroke · 2020–2026· 2 renewals
R01NS114561-05

Completed grants (5)

MPI
STALLED CAPILLARY FLOW: A NOVEL MECHANISM FOR HYPOPERFUSION IN ALZHEIMER DISEASE
National Institute on Aging · 2019–2021 · via Cornell University - Ithaca
R01AG049952-05S1
KP
A Novel Ischemic Stroke Model Triggered by Endothelial Dysfunction
National Institute of Neurological Disorders and Stroke · 2018–2021
R21NS104512-01
Sub-PI
Sphingosine-1-Phosphate in Neurovascular Biology and Disease
Fondation Leducq · 2016–2019 · via Boston Children's Hospital (Children's Hospital Corporation)
14CVD02
KP
Receptor-Degradative Functional Antagonists of S1P2 to Treat Pathological Angiogenesis and Fibrosis
Tri-Institutional Therapeutics Discovery Institute, Inc. · 2016–2017
TRI-TDII 16060923-01
PI
Sphingolipid Signaling in Endothelial Responses to Injury
NHLBI · 2009–2016 · via NIH RePORTER
R01HL094465-05

Dr. Teresa Sanchez Awarded the Established Investigator Award from the American Heart Association
June 12, 2025
Dr. Teresa Sanchez, associate professor of pathology and laboratory medicine and associate professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, has been awarded the highly competitive Established Investigator Award from the American Heart Association.